Nov 25, 2025 09:15AM
Nov 25, 2025 09:15AM
Aug 20, 2025 09:15AM
Aug 20, 2025 09:15AM
May 21, 2024 09:00AM
May 21, 2024 09:00AM
Nov 15, 2023 08:30AM PharmaCyte Biotech (PMCB) Acquires $5M Stake in Femasys (FEMY)
Nov 15, 2023 08:30AM
Nov 15, 2023 07:32AM
Nov 15, 2023 07:30AM
Oct 31, 2023 09:18AM
Oct 31, 2023 09:15AM
Jun 15, 2023 09:15AM
May 11, 2023 08:30AM PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share
Feb 2, 2023 09:00AM
Feb 2, 2023 09:00AM
Oct 7, 2022 09:01AM
Oct 7, 2022 09:00AM
Aug 15, 2022 08:34AM
Aug 15, 2022 08:30AM
Jul 28, 2022 12:52PM PharmaCyte Biotech, Inc (PMCB) Rebukes Iroquois’ Commencement of Consent Solicitation
Jul 28, 2022 12:49PM
Jul 21, 2022 08:30AM
Jul 19, 2022 08:32AM
Jul 19, 2022 08:30AM
Jul 11, 2022 08:30AM
Jul 11, 2022 06:00AM
Jul 5, 2022 08:30AM PharmaCyte Biotech Announces Additional Quality Control Assay and Confirms Stability of CypCap Cells
Jun 23, 2022 09:00AM
Jun 15, 2022 08:35AM
Jun 15, 2022 08:30AM
Jun 13, 2022 08:30AM
Jun 9, 2022 09:07AM
Jun 9, 2022 09:00AM
Jun 8, 2022 08:34AM PharmaCyte Biotech, Inc (PMCB) Issues Response to Iroquois Capital
Jun 8, 2022 08:30AM
Jun 2, 2022 09:01AM
Jun 2, 2022 09:00AM
May 23, 2022 09:00AM
May 11, 2022 09:03AM
May 11, 2022 09:00AM
Apr 27, 2022 09:00AM PharmaCyte Biotech to Attend 15th International Conference on Advanced Technologies and Treatments for Diabetes
Apr 19, 2022 09:01AM
Apr 19, 2022 09:00AM
Apr 13, 2022 09:03AM
Apr 13, 2022 09:00AM
Apr 5, 2022 09:00AM
Mar 22, 2022 09:00AM
Mar 16, 2022 09:00AM PharmaCyte Biotech Reports Third Quarter Financial Results and Operational Highlights
Feb 22, 2022 09:00AM

322,899 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All